Biospecimen Repository for Cardiac Arrhythmias at the Cleveland Clinic
Recruitment status was Recruiting
The long-term objective of this research is to find genes and biologic pathways causing arrhythmia syndromes and other diseases or conditions. In order to achieve this objective the investigators will collect comprehensive phenotypic data and corresponding blood and/or tissue samples into a biorepository registry of patients, presenting for cardiac arrhythmia evaluation and/or treatment, and control subjects without arrhythmias. This biorepository will be composed of two parts: 1) An Arrhythmia Biorepository of blood and tissue from patients undergoing arrhythmia procedures, cardiac surgery, or inpatient or outpatient evaluations for arrhythmias, and 2) A Collaborative Sample Biorepository for deidentified samples and data from outside institutions and clinical trials.
|Study Design:||Observational Model: Case Control
Time Perspective: Prospective
|Official Title:||Cleveland Clinic Arrhythmia Biospecimen Repository (Cleveland Clinic Arrhythmia BioBank)|
- Various Arrhythmias [ Time Frame: Indefinite ] [ Designated as safety issue: No ]
Biospecimen Retention: Samples With DNA
Biospecimens to be collected: DNA, RNA, plasma, & serum. Also tissue may be collected.
|Study Start Date:||March 2009|
Patients with arrhythmias
Subjects that do not have a history of cardiac arrhythmias.
One time blood draw and follow up in one year.
|Contact: Mina K. Chung, MDfirstname.lastname@example.org|
|Contact: Diana I. Bauer, BSemail@example.com|
|United States, Ohio|
|Cleveland Clinic Foundation||Recruiting|
|Cleveland, Ohio, United States, 44195|
|Principal Investigator: Mina K. Chung, MD|
|Sub-Investigator: David R. Van Wagoner, Ph.D.|
|Sub-Investigator: Jonathan D. Smith, Ph.D.|
|Sub-Investigator: John Barnard, Ph.D.|
|Principal Investigator:||Mina K. Chung, MD||The Cleveland Clinic|